BGI's wide range of mass spec-based Proteomic and Metabolomic services are increasingly combined with genomics information in Multi-Omics studies.
A multi-omics approach allows more complete insight into the molecular changes driving both normal cellular development and disease, and is powering the discovery of novel drug targets and biomarkers.
Contact us today and learn how our deep multi-omics experience can make a difference in your project.
We're offering a special 25% off correlation analysis if you are undertaking a combined Sequencing and Mass Spec project:
Transcriptome + ProteomeTerms and conditions: 1) US Customers only, cannot be combined with other promotion; 2) Only one promotional offer for each customer; 3) Applicable tax applies; 4) Offer expires 4/30/2022; 5) Samples must be received by 6/1/2022
We can provide broad support for drug discovery and other biologic-related proteomics and metabolomics services, including large-scale proteomics, phosphoproteomics, and trans-omics projects involving proteomic and transcriptomic analyses. All of our proteomic services can be customized to meet your drug discovery project needs.
BGI now offers a complete line of mass spectrometry services for all your research and drug development needs. Our laboratories around the worlds are staffed by experienced scientists, equipped with high-resolution LC-MS instrumentation and advanced bioinformatics capabilities.
Whatever your project needs, we are confident we have a solution to match.
CopyrightⒸ BGI 2023. All rights reserved. All product names, logos, and brands are property of their respective owners. All company, product and service names used in this email are for identification purposes only. Use of these names, logos, and brands does not imply endorsement. This email contains information on services or products targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration, or usage in the country of your origin. We hereby disclose that this email communication is for commercial purposes. Unless otherwise informed, certain sequencers and sequencing reagents are not available in selected countries or regions. Please get in touch with a representative for regional availability. The company reserves the right of final interpretation.